Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 150

Baruch, K., Gur-Arie, L., Nadler, C., et al., 2011. Metalloprotease type III effectors that speciically
cleave JNK and NF-kappaB. EMBO J. 30 (1), 221-231 .
Batchelor, M., Prasannan, S., Daniell, S., et al., 2000. Structural basis for recognition of the
translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coli . EMBO
J. 19 (11), 2452-2464 .
Batisson, I., Guimond, M.P., Girard, F., et al., 2003. Characterization of the novel factor paa involved
in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli . Infect.
Immun. 71 (8), 4516-4525 .
Beebakhee, G., Louie, M., De Azavedo, J., et al., 1992. Cloning and nucleotide sequence of the
eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7. FEMS
Microbiol. Lett. 70 (1), 63-68 .
Bell, B.P., Goldoft, M., Grifin, P.M., et al., 1994. A multistate outbreak of Escherichia coli
O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The
Washington experience JAMA 272 (17), 1349-1353 .
Bell, B.P., Grifin, P.M., Lozano, P., et al., 1997. Predictors of hemolytic uremic syndrome in
children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100 (1),
E12 .
Bellisola, G., Fracasso, G., Ippoliti, R., et al., 2004. Reductive activation of ricin and ricin A-chain
immunotoxins by protein disulide isomerase and thioredoxin reductase. Biochem. Pharmacol.
67 (9), 1721-1731 .
Berin, M.C., Darfeuille-Michaud, A., Egan, L.J., et al., 2002. Role of EHEC O157:H7 virulence
factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and
the upregulated expression of interleukin 8. Cell Microbiol. 4 (10), 635-648 .
Berry, E.D., Wells, J.E., 2010. Escherichia coli O157:H7 recent advances in research on
occurrence, transmission, and control in cattle and the production environment. Adv. Food
Nutr. Res. 60, 67-117 .
Besbas, N., Karpman, D., Landau, D., et al., 2006. A classiication of hemolytic uremic
syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 70
(3), 423-431 .
Besser, T.E., Shaikh, N., Holt, N.J., et al., 2007. Greater diversity of Shiga toxin-encoding bacterio-
phage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from
humans. Appl. Environ. Microbiol. 73 (3), 671-679 .
Best, A., La Ragione, R.M., Sayers, A.R., et al., 2005. Role for lagella but not intimin in the
persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by shiga
toxin-negative Escherichia coli O157:H7. Infect. Immun. 73 (3), 1836-1846 .
Beutin, L., Kruger, U., Krause, G., et al., 2008. Evaluation of major types of Shiga toxin 2E-producing
Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for
humans. Appl. Environ. Microbiol. 74 (15), 4806-4816 .
Bielaszewska, M., Idelevich, E.A., Zhang, W., et al., 2012. Effects of antibiotics on Shiga toxin 2
production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimi-
crob. Agents Chemother. 56 (6), 3277-3282 .
Bitzan, M., Richardson, S., Huang, C., et al., 1994. Evidence that verotoxins (Shiga-like toxins)
from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro . Infect.
Immun. 62 (8), 3337-3347 .
Blackall, D.P., Marques, M.B., 2004. Hemolytic uremic syndrome revisited: Shiga toxin, factor H,
and ibrin generation. Am. J. Clin. Pathol. 121 (Suppl.), S81-S88 .
Boerlin, P., McEwen, S.A., Boerlin-Petzold, F., et al., 1999. Associations between virulence factors
of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37 (3),
497-503 .